Edition:
United States

CytRx Corp (CYTR.OQ)

CYTR.OQ on NASDAQ Stock Exchange Capital Market

1.70USD
20 Apr 2018
Change (% chg)

$-0.04 (-2.02%)
Prev Close
$1.74
Open
$1.68
Day's High
$1.73
Day's Low
$1.66
Volume
18,881
Avg. Vol
58,473
52-wk High
$5.99
52-wk Low
$1.45

Select another date:

Wed, Apr 18 2018

BRIEF-Cytrx Presents Statistically Significant Breakthrough Data For Its Albumin Binding Ultra High Potency Ladr Drug Candidates

* CYTRX PRESENTS STATISTICALLY SIGNIFICANT BREAKTHROUGH DATA FOR ITS ALBUMIN BINDING ULTRA HIGH POTENCY LADR DRUG CANDIDATES

BRIEF-CytRx Selects Four New LADR™ Ultra High Potency Drug Candidates For Advancement Toward Clinical Trials

* CYTRX SELECTS FOUR NEW LADR™ ULTRA HIGH POTENCY DRUG CANDIDATES FOR ADVANCEMENT TOWARD CLINICAL TRIALS

BRIEF-Cytrx Corp Announces Its Entry Into A Definitive Agreement With Destum Partners

* CYTRX CORP - ANNOUNCED ITS ENTRY INTO A DEFINITIVE AGREEMENT WITH DESTUM PARTNERS

BRIEF-Cytrx announces new shareholder initiatives

* Cytrx Corporation provides business update and announces new shareholder initiatives

BRIEF-Cytrx reports strategic realignment of clinical development team

* Cytrx announces strategic realignment of clinical development team

BRIEF-Cytrx Corp announces reverse stock split

* Cytrx Corp- ‍1-for-6 reverse​ stock split will become effective as of commencement of trading on Wednesday, November 1, 2017 Source text for Eikon: Further company coverage:

Select another date: